Rakuten Medical, Inc., a worldwide biotechnology firm focused on developing and commercializing precision, cell-targeting Alluminox platform-based photoimmunotherapy, declared the launch of its global multi-regional phase 3 clinical trial...
.JPG)
Pharmaceutical company Lupin announced that it has received authorization from the US health authority to commercialize generic HIV drug in the US market. The Mumbai-based drug manufacturer announced in a statement that it has obtained provisional...
Jaguar Health, Inc. (Jaguar) affiliated companies Napo Pharmaceuticals (Napo) and Napo Therapeutics announced that the first patient has received a dose in the independent investigator-led POC trial of crofelemer, Jaguar's innovative plant-derived...
Genethon, a frontrunner in the research and development of gene therapies for rare conditions, and Eukarÿs, a biotech firm innovating a breakthrough technology that greatly enhances biomanufacturing yields, announced the signing of a strategic...
ENA Respiratory, a clinical-stage pharmaceutical firm focused on creating antiviral host defense immune boosters to reduce the effects of viral respiratory infections in vulnerable groups, reports that it has successfully finalized dosing for the...
The Indian pharmaceutical and healthcare sector holds significant hopes for the forthcoming Union Budget 2025, as stated in a report by CareEdge Ratings. The industry is requesting greater government assistance to enhance infrastructure and...
Emcure Pharmaceuticals Ltd, based in Pune, opened its largest Formulation Research and Development Centre in Ahmedabad, aimed at facilitating advancements in complex drug delivery methods. The newly established Emcure Research Centre will...
The cell therapy market is swiftly progressing, propelled by significant breakthroughs in medical research and a growing embrace of novel treatments in various therapeutic fields. The global industry is estimated to be valued at US$ 4.8 billion in...
Conduit Pharmaceuticals Inc. announced that it has established a strategic services partnership with the formulation development CDMO Agility Life Sciences (“Agility”) to create new solid oral-dosage form products for its autoimmune pipeline...
Tris Pharma, Inc. (Tris), a biopharmaceutical company in the commercial stage, revealed encouraging topline findings from its ALLEVIATE-1 crucial Phase 3 clinical trial assessing cebranopadol, an experimental treatment, for addressing moderate-to...
, CDSCO.jpg)
